Discovery may lead to a treatment to slow Parkinson’s disease

Scientists have shown that the most common genetic cause of Parkinson’s disease — a mutant LRRK2 kinase enzyme — contributes to the formation of inclusions in neurons, resembling one of the hallmark pathologies seen in Parkinson’s disease. These inclusions are made up of aggregated alpha synuclein protein, which — the research also shows — can be prevented from forming by using two LRRK2 kinase inhibitor drugs now being developed for clinical use. Click the link below to read the full article…

Source: Science Daily

UAB Neurology – 2015 Parkinson’s Research Progress Report

The Parkinson Association of Alabama is thankful for it’s partnership with UAB and proud of their ongoing research contributions to accelerate a cure for Parkinson’s Disease. We are excited to share the 2015 Parkinson’s Research Progress Report from the UAB Department of Neurology and hope you’ll take a moment to review.